small molecule manufacturing

Excelsior Sciences leverages blocc chemistry, an automated, AI-friendly small molecule synthesis platform, to accelerate drug discovery and scale from molecule to manufacturing. The company is developing its own proprietary therapeutic pipeline while collaborating with partners in pharmaceuticals, materials science, and agtech. Its closed-loop discovery and manufacturing platform combines proprietary chemistry with AI-guided automated iterative synthesis and testing.

Read more

AI-guided closed-loop discoveryautomated iterative synthesiscarbon-carbon bond formation